• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Assessing implementation mechanisms for an international agreement on research and development for health products.评估一项关于卫生产品研发的国际协议的实施机制。
Bull World Health Organ. 2012 Nov 1;90(11):854-63. doi: 10.2471/BLT.12.109827. Epub 2012 Oct 11.
2
Making G8 leaders deliver: an analysis of compliance and health commitments, 1996-2006.促使八国集团领导人履行承诺:对1996年至2006年合规与健康承诺的分析
Bull World Health Organ. 2007 Mar;85(3):192-9. doi: 10.2471/blt.06.039917.
3
WHO's role in the global health system: what can be learned from global R&D debates?世卫组织在全球卫生系统中的作用:从全球研发辩论中可以吸取哪些经验?
Public Health. 2014 Feb;128(2):167-72. doi: 10.1016/j.puhe.2013.08.014. Epub 2014 Jan 3.
4
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
5
Strengthening the WHO in the pandemic era by removing a persistent structural defect in financing.在大流行时代加强世界卫生组织,消除其融资结构中持续存在的缺陷。
Global Health. 2021 Dec 15;17(1):142. doi: 10.1186/s12992-021-00780-7.
6
7
An agenda for action in sub-Saharan Africa. A collaborative initiative of the World Bank, UNFPA and IPPF.撒哈拉以南非洲地区的行动议程。世界银行、联合国人口基金和国际计划生育联合会的一项合作倡议。
Integration. 1991 Mar(27):10-7.
8
The Minderoo-Monaco Commission on Plastics and Human Health.美诺集团-摩纳哥基金会塑料与人体健康委员会
Ann Glob Health. 2023 Mar 21;89(1):23. doi: 10.5334/aogh.4056. eCollection 2023.
9
International occupational health.国际职业健康
Int J Hyg Environ Health. 2003 Aug;206(4-5):303-13. doi: 10.1078/1438-4639-00226.
10
Fighting trafficking of falsified and substandard medicinal products in Russia.打击俄罗斯假药和劣药的非法交易。
Int J Risk Saf Med. 2015;27 Suppl 1:S37-40. doi: 10.3233/JRS-150681.

引用本文的文献

1
International treaties have mostly failed to produce their intended effects.国际条约大多未能产生预期效果。
Proc Natl Acad Sci U S A. 2022 Aug 9;119(32):e2122854119. doi: 10.1073/pnas.2122854119. Epub 2022 Aug 1.
2
A 'whole of United Nations approach' to tackle antimicrobial resistance? A mapping of the mandate and activities of international organisations.采取“联合国整体办法”防治抗微生物药物耐药性? 对国际组织的任务和活动进行的制图。
BMJ Glob Health. 2022 May;7(5). doi: 10.1136/bmjgh-2021-008181.
3
How many people must die from pandemics before the world learns?在世界吸取教训之前,要有多少人死于大流行病?
Glob Chall. 2016 Nov 15;1(1):30-32. doi: 10.1002/gch2.1011. eCollection 2017 Jan.
4
Impact of the WHO Framework Convention on Tobacco Control on global cigarette consumption: quasi-experimental evaluations using interrupted time series analysis and in-sample forecast event modelling.世界卫生组织烟草控制框架公约对全球卷烟消费的影响:使用中断时间序列分析和样本内预测事件建模的准实验评估。
BMJ. 2019 Jun 19;365:l2287. doi: 10.1136/bmj.l2287.
5
Delays in Global Disease Outbreak Responses: Lessons from H1N1, Ebola, and Zika.全球疾病爆发应对中的延误:从 H1N1、埃博拉和寨卡病毒中吸取的教训。
Am J Public Health. 2018 Mar;108(3):329-333. doi: 10.2105/AJPH.2017.304245. Epub 2018 Jan 18.
6
Navigating institutional complexity in the health sector: lessons from tobacco control in Kenya.应对卫生部门的机构复杂性:肯尼亚烟草控制的经验教训。
Health Policy Plan. 2016 Dec;31(10):1402-1410. doi: 10.1093/heapol/czw094. Epub 2016 Jul 14.
7
International law's effects on health and its social determinants: protocol for a systematic review, meta-analysis, and meta-regression analysis.国际法对健康及其社会决定因素的影响:系统评价、荟萃分析和荟萃回归分析方案
Syst Rev. 2016 Apr 16;5:64. doi: 10.1186/s13643-016-0238-0.
8
Strategies for achieving global collective action on antimicrobial resistance.实现全球抗菌药物耐药性集体行动的策略。
Bull World Health Organ. 2015 Dec 1;93(12):867-76. doi: 10.2471/BLT.15.153171. Epub 2015 Oct 13.
9
Assessing Proposals for New Global Health Treaties: An Analytic Framework.评估新的全球卫生条约提案:一个分析框架
Am J Public Health. 2015 Aug;105(8):1523-30. doi: 10.2105/AJPH.2015.302726. Epub 2015 Jun 11.
10
An international legal framework to address antimicrobial resistance.应对抗菌药物耐药性的国际法律框架。
Bull World Health Organ. 2015 Feb 1;93(2):66. doi: 10.2471/BLT.15.152710.

本文引用的文献

1
WHO's undermining tobacco control.世界卫生组织正在破坏烟草控制。
Lancet. 2012 Aug 25;380(9843):727-8. doi: 10.1016/S0140-6736(12)61402-0.
2
Securing the public good of health research and development for developing countries.为发展中国家保障健康研究与开发的公共利益。
Bull World Health Organ. 2012 May 1;90(5):398-400. doi: 10.2471/BLT.12.105460.
3
IHP+: little progress in accountability or just little progress?国际卫生伙伴关系计划(IHP+):问责制进展甚微还是仅仅略有进展?
Lancet. 2010 May 1;375(9725):1505-7. doi: 10.1016/S0140-6736(10)60625-3.
4
Making G8 leaders deliver: an analysis of compliance and health commitments, 1996-2006.促使八国集团领导人履行承诺:对1996年至2006年合规与健康承诺的分析
Bull World Health Organ. 2007 Mar;85(3):192-9. doi: 10.2471/blt.06.039917.
5
Public health, innovation and intellectual property rights: unfinished business.公共卫生、创新与知识产权:未竟之事。
Bull World Health Organ. 2006 May;84(5):338. doi: 10.2471/blt.06.031880. Epub 2006 May 17.
6
The patents-based pharmaceutical development process: rationale, problems, and potential reforms.基于专利的药物研发过程:基本原理、问题及潜在改革。
JAMA. 2005 Oct 26;294(16):2075-82. doi: 10.1001/jama.294.16.2075.

评估一项关于卫生产品研发的国际协议的实施机制。

Assessing implementation mechanisms for an international agreement on research and development for health products.

机构信息

McMaster Health Forum and Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada.

出版信息

Bull World Health Organ. 2012 Nov 1;90(11):854-63. doi: 10.2471/BLT.12.109827. Epub 2012 Oct 11.

DOI:10.2471/BLT.12.109827
PMID:23226898
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3506410/
Abstract

The Member States of the World Health Organization (WHO) are currently debating the substance and form of an international agreement to improve the financing and coordination of research and development (R&D) for health products that meet the needs of developing countries. In addition to considering the content of any possible legal or political agreement, Member States may find it helpful to reflect on the full range of implementation mechanisms available to bring any agreement into effect. These include mechanisms for states to make commitments, administer activities, manage financial contributions, make subsequent decisions, monitor each other's performance and promote compliance. States can make binding or non-binding commitments through conventions, contracts, declarations or institutional reforms. States can administer activities to implement their agreements through international organizations, sub-agencies, joint ventures or self-organizing processes. Finances can be managed through specialized multilateral funds, financial institutions, membership organizations or coordinated self-management. Decisions can be made through unanimity, consensus, equal voting, modified voting or delegation. Oversight can be provided by peer review, expert review, self-reports or civil society. Together, states should select their preferred options across categories of implementation mechanisms, each of which has advantages and disadvantages. The challenge lies in choosing the most effective combinations of mechanisms for supporting an international agreement (or set of agreements) that achieves collective aspirations in a way and at a cost that are both sustainable and acceptable to those involved. In making these decisions, WHO's Member States can benefit from years of experience with these different mechanisms in health and its related sectors.

摘要

世界卫生组织(世卫组织)会员国目前正在讨论一项国际协议的实质内容和形式,以改善满足发展中国家需求的卫生产品研发的供资和协调。除了审议任何可能的法律或政治协定的内容外,会员国不妨考虑将任何协定付诸实施的所有执行机制。这些机制包括各国作出承诺、管理活动、管理财政捐款、作出后续决定、相互监督执行情况和促进遵守的机制。各国可以通过公约、合同、宣言或体制改革作出有约束力或无约束力的承诺。各国可以通过国际组织、次级机构、合资企业或自主组织的进程管理活动以执行其协定。资金可以通过专门的多边基金、金融机构、成员组织或协调的自我管理来管理。可以通过一致同意、协商一致、平等表决、修正表决或授权作出决定。监督可以通过同行审查、专家审查、自我报告或民间社会提供。各国应在各种执行机制类别中选择其偏爱的方案,每一种机制都有其优点和缺点。挑战在于选择最有效的机制组合,以支持以可持续和可接受的方式和成本实现集体愿望的国际协定(或一套协定)。在作出这些决定时,世卫组织会员国可以借鉴在卫生及其相关部门使用这些不同机制方面多年的经验。